tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

Paysafe (PSFE) Q2 2026 Earnings Call: Revenue Rises 4%, Deleveraging in Focus

Paysafe’s Q2 2026 earnings call covered 4% revenue growth, lower adjusted EBITDA, stronger Merchant Solutions results and a continued focus on deleveraging.
iconPaysafe Ltd
TradingKey
Fri, Aug 14

Protalix BioTherapeutics (PLX) Q2 2026 Earnings Call: Elfabrio Drives Revenue Growth

Protalix BioTherapeutics Q2 2026 revenue rose 26.8% to $19.9 million as Elfabrio drove growth, while management reaffirmed its full-year outlook.
iconProtalix Biotherapeutics Inc
TradingKey
Fri, Aug 14

Perma-Fix (PESI) Fiscal Q2 2026 Earnings Call: $6.2M Loss, Hanford Grouting Award

Perma-Fix Q2 2026 revenue fell to $12.9 million with a $6.2 million loss, while backlog grew and the company advanced its Hanford grouting program.
iconPerma-Fix Environmental Services Inc
TradingKey
Fri, Aug 14

PFG Q4 Fiscal 2026 Earnings Call: FY2027 Adjusted EBITDA Guided to $2.125B-$2.225B

PFG’s fiscal Q4 2026 earnings call covered 6.4% sales growth, $587.5 million adjusted EBITDA and fiscal 2027 guidance of up to $2.225 billion.
iconPerformance Food Group Co
TradingKey
Fri, Aug 14

Pelagos Insurance Capital (PLGO) Q2 2026 Earnings Call: Premium Growth, Large Losses and Outlook

Pelagos Insurance Capital’s Q2 2026 earnings call covered 6% premium growth, a 99.5% combined ratio, $162 million of large losses and maintained 2026 targets.
iconFidelis Insurance Holdings Ord Shs
TradingKey
Fri, Aug 14

PetMed Express (PETS) Fiscal Q1 2027 Earnings Call: Sales Stabilize Above $40 Million

PetMed Express (PETS) fiscal Q1 2027 earnings call: sales fell 19.9% to $41 million, net loss narrowed, and customer acquisition costs declined 15%.
iconPetmed Express Inc
TradingKey
Fri, Aug 14

PED Q2 2026 Earnings Call: Revenue Rises 561%, EBITDA Guidance Reaffirmed

PED Q2 2026 revenue rose 561% to $46.1 million as oil prices offset lower production. Management reaffirmed $60 million-$70 million EBITDA guidance.
iconPEDEVCO Corp
TradingKey
Fri, Aug 14

Nomad Foods (NOMD) Q2 2026 Earnings Call: Pricing, Market Share Recovery and Deleveraging

Nomad Foods Q2 2026 earnings call covers pricing-led gross margin growth, resolved retail disruptions, its EUR 200 million productivity plan and deleveraging.
iconNomad Foods Ltd
TradingKey
Fri, Aug 14

Oxbridge (OXBR) Q2 2026 Earnings Call: Profitability Returns as AI GridWorks Launches

Oxbridge’s Q2 2026 earnings call covered a return to $176,000 net income, SurancePlus tokenized reinsurance growth and the launch of AI GridWorks.
iconOxbridge Re Holdings Ltd
TradingKey
Fri, Aug 14

OptimizeRx (OPRX) Fiscal Q2 2026 Earnings Call: Guidance Reaffirmed as Revenue Falls 30%

OptimizeRx Q2 2026 revenue fell 30% to $20.5 million, while management reaffirmed its $95 million-$100 million full-year revenue guidance.
iconOptimizeRx Corp
TradingKey
Fri, Aug 14

Ondas (ONDS) Q2 2026 Earnings Call: Revenue Guidance Raised as Backlog Reaches $757 Million

Ondas Q2 2026 revenue reached $83.8 million as backlog rose to $757 million. Management raised 2026 revenue guidance to $525 million-$550 million.
iconOndas Holdings Inc
TradingKey
Fri, Aug 14

Octave (OCTV) Q2 2026 Earnings Call: SaaS Up 21%, Outlook Cut

Octave’s Q2 2026 earnings call covered 7% ARR growth, 21% SaaS growth, strong cash flow and a reduced full-year revenue outlook tied to delayed perpetual deals.
iconOctave Intelligence Ord Shs Class B
TradingKey
Fri, Aug 14

Omeros (OMER) Q2 2026 Earnings Call: YARTEMLEA Sales Reach $28.5 Million

Omeros Q2 2026 earnings call: YARTEMLEA net sales reached $28.5 million, operations generated $4.1 million in cash, and convertible debt declined 43%.
iconOmeros Corp
TradingKey
Fri, Aug 14

Nu Holdings (NU) Q2 2026 Earnings Call: Net Income Reaches $1.1 Billion

Nu Holdings' Q2 2026 earnings call covered record $1.1 billion net income, 12.4% risk-adjusted NIM, 37% loan growth and a 20% efficiency outlook.
iconNu Holdings Ltd
TradingKey
Fri, Aug 14

Nuwellis (NUWE) Q2 2026 Earnings Call: Revenue Rises 14%, Gross Margin Reaches 76%

Nuwellis Q2 2026 earnings call: revenue rose 14% to $1.97 million, gross margin reached 76%, and Aquadex console sales increased to nine.
iconNuwellis Inc
TradingKey
Fri, Aug 14

Nebius Group (NBIS) Q2 2026 Earnings Call: Revenue Rises 454%, Guidance Reaffirmed

Nebius Group Q2 2026 revenue rose 454% to $582 million, adjusted EBITDA reached $236 million, and management reaffirmed its full-year guidance.
iconNebius Group NV
TradingKey
Fri, Aug 14

NeuroOne (NMTC) Fiscal Q3 2026 Earnings Call: Orders Rise 43%, Margin Reaches 59.9%

NeuroOne’s fiscal Q3 2026 earnings call covered 16% revenue growth, a 59.9% gross margin, $2.7 million in orders and manufacturing-constrained guidance.
iconNeuroOne Medical Technologies Corp
TradingKey
Fri, Aug 14

Newsmax (NMAX) Q2 2026 Earnings Call: First Public-Company Profit, Guidance Reaffirmed

Newsmax (NMAX) Q2 2026 earnings call: revenue rose 16.5% to $54.1M, net income reached $2.9M, and 2026 guidance remained $212M–$216M.
iconNewsmax Ord Shs Class B
TradingKey
Fri, Aug 14

MaxCyte (MXCT) Q2 2026 Earnings Call: Guidance Reaffirmed as Genentech Partnership Expands

MaxCyte Q2 2026 revenue fell 15% to $7.3 million, while costs declined and 2026 guidance was maintained. Genentech and DTx support second-half growth.
iconMaxCyte Inc
TradingKey
Fri, Aug 14

MSG Sports (MSGS) Fiscal Q4 2026 Earnings Call: Knicks Title Lifts Revenue

MSG Sports fiscal Q4 2026 revenue reached $278.7 million as the Knicks’ title run lifted playoff sales. Management also outlined the Rangers spin-off.
iconMadison Square Garden Sports Corp
TradingKey
Fri, Aug 14
Featured Tools
marketing_marketsTitleMarketscalendar_economicCalendarEconomic Calendarsearch.intelligent.strategySmartPicksarticle_asider_weekly_reportWeekly Report
Popular Instruments
link
Name
Price
Chg%
US30
US30
US30
--
--
NAS100
NAS100
NAS100
--
--
SPX500
SPX500
US500
--
--
Top News
link
【US Pre-Market】US Stock Futures Rise Across the Board, Celestica Surges Over 15%, Gold Fluctuates Around $4,000, Bitcoin Drops Below $80,000 Level
Anthropic Publicly Files for Nasdaq IPO: Half-Year Revenue of $16.3 Billion, Net Loss of $80.7 Billion
Gold Rebounds Above $4,000 Ahead of Fed Decision as Oil Pullback Eases Inflation Fears
Meta Gains 0.12% Pre-Market as Nvidia Plans to Buy $3 Billion of Its Stock and Deepen Muse AI Collaboration
The Week Ahead: Fed Rate Decision Looming as Microsoft, Alphabet, and Amazon Report Earnings
Market Movers
link
Eaton Corporation PLC Stock (ETN) Moved Up by 3.33% on Oct 27: Facts Behind the Movement
49 minutes ago
ETN
--
Boeing Co Stock (BA) Moved Down by 9.88% on Oct 27: Drivers Behind the Movement
49 minutes ago
BA
--
Palo Alto Networks Inc Stock (PANW) Moved Up by 3.06% on Oct 27: Drivers Behind the Movement
49 minutes ago
PANW
--
Micron Technology Inc Stock (MU) Moved Up by 3.04% on Oct 27: A Full Analysis
50 minutes ago
MU
--
Accenture PLC Stock (ACN) Moved Down by 4.41% on Oct 27: Key Drivers Unveiled
50 minutes ago
ACN
--
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy